What is Travelers Vaccines Market?
Travelers vaccines, also known as travel immunizations are shots travelers can get before visiting certain areas of the world that help protect them from serious illnesses. The body responds to the vaccination by making antibodies that will protect you if you are exposed to the disease in the future. Travelers' vaccines are effective, and safe ways to help protect travelers from bringing home more than they bargained for, this is projected the growth of the market in the forecast period.
The market study is being classified by Type (Mono Vaccines and Combination Vaccines), by Application (Tourists, Students, Workers and Others) and major geographies with country level break-up.
GlaxoSmithKline plc (United Kingdom), Sanofi Pasteur (France), Merck & Co., Inc. (United States), Pfizer (United States), China National Pharmaceutical Group (China), Sanofi Pasteur MSD (France), Serum Institute of India (India) and Biokangtai (China) are some of the key players profiled in the study.
The Players having a strong hold in the market are GlaxoSmithKline plc, Sanofi Pasteur, and Merck & Co., Inc.. Research Analyst at AMA predicts that European Players will contribute to the maximum growth of Global Travelers Vaccines market throughout the predicted period.
Segment Analysis
Analyst at AMA have segmented the market study of Global Travelers Vaccines market by Type, Application and Region.
On the basis of geography, the market of Travelers Vaccines has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Drivers
- Rising Preferences for Outsourcing of Vaccine in the Under Developing and Developed Countries
- Extreme Low Risk of Serious Side Effects on the Fetus
Market Trend
- Increasing Globalization and International Travelling
Restraints
- Strict Norms and Regulatory Pathway
Opportunities
- Various Government and Nonprofit Organization are taking Educational & Awareness Programs Travelers Vaccines
Challenges
- High-cost Associated with Vaccine Transportation, Storage, and New Vaccine Discovery
Key Target Audience
Travelers Vaccines Providers, Potential Technology Investors, Regulatory & Government Bodies, Downstream Vendors and Other